VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death
- 5 February 2001
- journal article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 3 (2) , 145-152
- https://doi.org/10.1002/jgm.164
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Liposomal Encapsulation of Ganciclovir Enhances the Efficacy of Herpes Simplex Virus Type 1 Thymidine Kinase Suicide Gene Therapy against Hepatic Tumors in RatsHuman Gene Therapy, 1999
- Intravenous RMP-7 Increases Delivery of Ganciclovir into Rat Brain Tumors and Enhances the Effects of Herpes Simplex Virus Thymidine Kinase Gene TherapyHuman Gene Therapy, 1998
- Gene therapy - promises, problems and prospectsNature, 1997
- Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 GeneHuman Gene Therapy, 1997
- The Role of Interleukin-2 in Combination Adenovirus Gene Therapy for Head and Neck CancerMolecular Endocrinology, 1997
- Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatmentGene Therapy, 1997
- Glioma Cells Transduced with anEscherichia coliCD/HSV-1 TK Fusion Gene Exhibit Enhanced Metabolic Suicide and RadiosensitivityHuman Gene Therapy, 1997
- In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-FluorocytosineHuman Gene Therapy, 1995
- Up-Regulation of Keratin 17 Expression in Human HaCaT Keratinocytes by Interferon-γJournal of Investigative Dermatology, 1995
- In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumorsJournal of Neurosurgery, 1994